Mohamed‐Kamal Ibrahim

Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations

Fathalla Khedr, Mohamed‐Kamal Ibrahim, Ibrahim H. Eissa et al. · Archiv der Pharmazie · 2021 · 67 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4′,3′-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies

Khaled El‐Adl, Mohamed‐Kamal Ibrahim, Mohamed S. Alesawy et al. · Bioorganic & Medicinal Chemistry · 2020 · 65 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazolin-4(3H)-ones

Mohamed‐Kamal Ibrahim, Khaled El‐Adl, Ahmed A. Al‐Karmalawy · Bulletin of Faculty of Pharmacy Cairo University  · 2015 · 45 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

<i>N</i>‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies

Khaled El‐Adl, Mohamed‐Kamal Ibrahim, Fathalla Khedr et al. · Archiv der Pharmazie · 2020 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)-N-(4-(substituted)phenyl)acetamide derivatives for biological evaluation as anticonvulsant agents

Mohamed‐Kamal Ibrahim, Ashraf A. Abd-Elrahman, Rezk R. Ayyad et al. · Bulletin of Faculty of Pharmacy Cairo University  · 2012 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11